Novartis India Ltd.

Web: novartis.in NSE: NOVARTIND BSE: 500672 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1763 159(-9%)

Volume

77k as on 18, Sep

Open

955

High

975

Low

955

1,922

VWAP

2,069

52 Week High

2,589

52 Week Low

950

Viand Research Rating

Quality Score

12/100

Growth Score

10/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

4,353

No. of Shares

2.47

P/E

29.83

P/B

3.57

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

11.98

ROCE

Profit Growth

Listing Date

Rank/Sector Rank

#893/#82

Promoter Holding

70.68%

FII Holding

0.17%

DII Holding

0.53%

Price Chart

Price Performance

1 Week14%

1 Month28%

3 Months50%

6 Months106%

1 Year106%

YTD106%

Moving Average

5 Day SMA2,141

10 Day SMA2,043

20 Day SMA1,783

30 Day SMA1,713

50 Day SMA1,673

61 Day SMA1,634

80 Day SMA1,576

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	2,362	2,132	2,279	2,355
Resistance 2	2,279	2,116	2,209	2,275
Resistance 1	2,180	2,099	2,166	2,173
Pivot Point	2,097	2,082	2,097	2,093
Support 1	1,998	2,066	2,027	1,991
Support 2	1,915	2,049	1,984	1,911
Support 3	1,816	2,032	1,915	1,809

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%
FIIs	(0.01) 0.17%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(-0.11) 0.19%	(0.11) 0.32%	(0.11) 0.23%	(0.01) 0.17%	(0.01) 0.17%	(0.01) 0.17%	(0.01) 0.14%	(0.01) 0.12%	(0.01) 0.09%
DIIs	(-0.11) 0.53%	(0.11) 0.63%	(0.01) 0.53%	(0.01) 0.53%	(0.01) 0.53%	(0.01) 0.53%	(0.01) 0.52%	(0.01) 0.52%	(0.01) 0.52%	(0.01) 0.52%	(-0.21) 0.52%	(0.01) 0.75%	(0.01) 0.77%	(0.01) 0.77%	(0.01) 0.77%	(0.01) 0.78%	(0.01) 0.77%	(0.01) 0.78%
Public	28.60%	28.50%	28.61%	28.60%	28.61%	28.60%	28.61%	28.60%	28.61%	28.60%	28.47%	28.34%	28.38%	28.37%	28.37%	28.41%	28.43%	28.46%
No. of Shareholders	38,116	39,468	39,353	39,040	39,133	38,926	39,596	39,265	41,239	43,128	43,992	43,343	41,947	42,622	43,275	43,996	44,371	44,640

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	91	86	90	88	84	93	87	92	81	85	79	91	76	80	102	121	98	99	104
Sales Growth % (YoY)	-	-7.6%	3.7%	-5.1%	3.3%	10%	10.6%	1.9%	6.6%	5.4%	-22.4%	-25.1%	-22.6%	-19%	-2.8%	23.2%	-1%	5.5%	9%
Sales Growth % (QoQ)	5.8%	-4.4%	2.3%	4.8%	-9.7%	6.9%	-5.4%	13.6%	-4.7%	7.6%	-13.2%	19.7%	-5%	-21.6%	-15.7%	23.5%	-1%	-4.8%	-
Expenses	70	64	66	60	60	67	69	68	70	65	62	73	67	73	85	89	93	92	97
Operating Profit	21	22	24	27	24	26	18	24	11	20	17	17	9	8	16	32	6	7	7
OPM %	23	26	26	31	29	28	21	26	14	23	21	19	12	10	16	26	6	7	7
Other Income	10	9	9	11	11	11	10	10	10	22	17	12	16	8	7	27	-35	6	6
Interest	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	2
Depreciation	0	0	1	1	1	1	1	1	0	0	1	2	2	1	1	1	1	3	3
Profit before tax	30	30	33	37	34	35	28	34	21	41	32	28	23	14	21	57	-31	8	9
Tax %	16	46	26	26	14	28	26	24	31	36	27	27	-7	47	14	7	-25	24	24
Net Profit	25	16	24	28	29	25	20	26	15	27	24	20	25	8	18	52	-23	6	7
Net Profit Growth % (QoQ)	56.2%	-33.3%	-14.3%	-3.4%	16%	25%	-23.1%	73.3%	-44.4%	12.5%	20%	-20%	212.5%	-55.6%	-65.4%	326.1%	-483.3%	-14.3%	-
Net Profit Growth % (YoY)	-13.8%	-36%	20%	7.7%	93.3%	-7.4%	-16.7%	30%	-40%	237.5%	33.3%	-61.5%	208.7%	33.3%	157.1%	-	-	-	-
TTM Net Profit	93	97	106	102	100	86	88	92	86	96	77	71	103	55	53	42	-10	13	0
EPS in Rs	10.23	6.52	9.81	11.19	11.87	10.31	8.27	10.42	5.95	10.76	9.59	8.21	10.13	3.08	7.43	21.21	-9.47	2.57	2.84

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	354	356	335	379	400	381	438	491	564	656	690	870	859	901
Sales Growth %	-	6.3%	-11.5%	-5.3%	4.9%	-13%	-10.7%	-13%	-14.1%	-4.9%	-20.8%	1.3%	-4.6%	7%
Expenses	260	265	270	314	373	355	426	478	570	631	656	874	861	810
Operating Profit	94	91	65	65	27	27	12	12	-6	25	34	-4	-1	90
OPM %	27	26	19	17	7	7	3	2	-1	4	5	0	0	10
Other Income	39	42	62	58	-17	33	36	78	172	71	207	101	95	83
Interest	1	1	1	2	5	8	6	2	6	1	0	0	0	0
Depreciation	2	2	3	6	10	12	13	3	3	4	3	4	4	4
Profit before tax	130	130	123	115	-4	40	29	86	158	92	237	93	90	169
Tax %	28	23	31	10	-3	48	65	40	50	38	16	15	-10	29
Net Profit	93	101	85	103	-4	21	10	52	78	57	198	79	99	120
Net Profit Growth %	-7.9%	18.8%	-17.5%	2675%	-119%	110%	-80.8%	-33.3%	36.8%	-71.2%	150.6%	-20.2%	-17.5%	-
EPS in Rs	37.74	40.87	34.5	41.86	-1.51	8.46	4.08	20.97	31.74	20.33	62.04	24.75	30.83	37.46
Dividend Payout %	0	61	72	113	-663	118	245	48	32	49	16	40	32	27

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	75	113	45	39	-69	-23	-194	161	-41	57	-60	-5	7
Cash from Investing Activity	-3	33	-153	87	95	56	274	69	424	-630	719	22	-16
Cash from Financing Activity	-64	-121	-30	-36	-37	-41	-30	-268	-332	-39	-38	-38	-37
Net Cash Flow	7	26	-139	90	-11	-9	50	-38	51	-612	622	-20	-46

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	12	12	12	12	12	12	12	12	12	12	12	14	16	16	16	16
Reserves	805	763	773	717	732	763	679	699	708	747	721	906	1178	986	945	884
Borrowings	3	4	5	6	7	22	24	62	68	0	0	0	0	0	0	0
Other Liabilities	157	153	158	156	173	186	242	229	289	223	377	230	239	244	241	241
Total Liabilities	978	932	948	891	925	983	958	1002	1078	982	1111	1150	1433	1246	1202	1141
Fixed Assets	3	4	5	6	7	19	24	64	76	15	5	6	6	8	8	10
CWIP	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	975	928	943	885	918	964	934	938	1001	967	1106	1144	1426	1238	1194	1131
Total Assets	978	932	948	891	925	983	958	1002	1078	982	1111	1150	1433	1246	1202	1141

Delivery

Delivery Data: NOVARTIND

#	Date	1402 85% 2589	Value (Cr)	Q/T 10	Del 43	Del 43
1	21-Oct	1768	6	6	51	3
2	19-Oct	1922	2	6	50	1
3	16-Oct	1898	6	6	47	3
4	15-Oct	1940	4	8	54	2
5	14-Oct	1988	4	7	36	2
6	13-Oct	1992	9	11	61	5
7	12-Oct	2013	8	5	37	3
8	9-Oct	2049	10	7	34	3
9	8-Oct	1988	7	7	40	3
10	7-Oct	2010	12	8	45	6
11	6-Oct	2051	10	6	39	4
12	5-Oct	1968	40	16	24	10
13	1-Oct	1965	8	8	41	3
14	30-Sep	1919	5	7	41	2
15	29-Sep	1924	4	8	43	2
16	28-Sep	1935	8	7	33	3
17	25-Sep	1966	3	7	37	1
18	24-Sep	1971	6	10	44	3
19	23-Sep	2027	16	7	28	4
20	22-Sep	1973	9	10	37	3
21	21-Sep	2004	7	11	51	4
22	18-Sep	2047	16	10	35	6
23	17-Sep	2082	33	14	30	10
24	16-Sep	1996	25	11	42	11
25	15-Sep	2188	30	12	31	9
26	11-Sep	2391	110	12	16	17
27	10-Sep	2428	564	13	15	85
28	9-Sep	2186	163	14	21	34
29	8-Sep	1822	99	12	12	12
30	7-Sep	1640	12	11	39	5
31	4-Sep	1647	4	12	74	3
32	3-Sep	1614	3	10	74	2
33	2-Sep	1602	1	7	58	1
34	1-Sep	1582	3	7	43	2
35	31-Aug	1554	5	7	52	3
36	28-Aug	1486	1	8	56	0
37	27-Aug	1490	1	9	62	1
38	26-Aug	1490	1	8	73	1
39	25-Aug	1486	1	9	67	1
40	24-Aug	1502	4	9	51	2
41	21-Aug	1419	4	9	57	2
42	20-Aug	1482	2	9	64	2
43	19-Aug	1532	2	9	68	1
44	18-Aug	1596	1	4	54	0
45	17-Aug	1589	3	8	61	2
46	14-Aug	1582	3	7	60	2
47	13-Aug	1548	2	6	57	1
48	12-Aug	1592	2	8	56	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	4,353c	387c	8.17
19-Oct	4,740c	96c	2.07
17-Oct	4,644c	0	0
16-Oct	4,644c	146c	3.05
15-Oct	4,790c	99c	2.03
14-Oct	4,889c	56c	1.14
13-Oct	4,946c	7c	0.15
12-Oct	4,938c	79c	1.63
09-Oct	4,859c	99c	1.99
08-Oct	4,958c	148c	2.90
05-Oct	5,106c	351c	7.38
01-Oct	4,755c	5c	0.10
29-Sep	4,751c	17c	0.36
28-Sep	4,768c	47c	0.97
25-Sep	4,815c	116c	2.34
24-Sep	4,930c	22c	0.45
22-Sep	4,908c	384c	7.26
17-Sep	5,293c	1,065c	16.76
10-Sep	6,358c	2,264c	55.31
07-Sep	4,094c	5c	0.12
04-Sep	4,089c	0	0

Stock Checklist

Price is above from 52 week high low average: 50%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 8 fund scheme(s) across 2 fund house(s) as of Oct26 · Total value ₹17 Cr · 0 increasing / 6 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	6	0.15%	-0.04%	9.9
Edelweiss Mutual Fund	2	1.83%	-0.08%	7

Novartis India Ltd.

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements